HARVEST ONE CANNABIS INC (HVT.CA) Stock Price & Overview
TSX-V:HVT • CA41755P1053
Current stock price
The current stock price of HVT.CA is 0.03 CAD. Today HVT.CA is down by -14.29%. In the past year, price decreased by -64.71%.
HVT.CA Key Statistics
- Market Cap
- 7.579M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.05
- Dividend Yield
- N/A
HVT.CA Stock Performance
HVT.CA Stock Chart
HVT.CA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to HVT.CA. When comparing the yearly performance of all stocks, HVT.CA is a bad performer in the overall market: 85.7% of all stocks are doing better.
HVT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HVT.CA. HVT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
HVT.CA Earnings
HVT.CA Forecast & Estimates
For the next year, analysts expect an EPS growth of -14.64% and a revenue growth 50.65% for HVT.CA
HVT.CA Groups
Sector & Classification
HVT.CA Financial Highlights
Over the last trailing twelve months HVT.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 88.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -161.5% | ||
| ROA | -102.61% | ||
| ROE | N/A | ||
| Debt/Equity | 0.3 |
HVT.CA Ownership
HVT.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| BHC | BAUSCH HEALTH COS INC | 1.25 | 2.931B | ||
| CRON | CRONOS GROUP INC | 41.04 | 1.42B | ||
| TLRY | TILRAY BRANDS INC | N/A | 1.117B | ||
| DHT-UN | DRI HEALTHCARE TRUST | 5.16 | 895.726M | ||
| GUD | KNIGHT THERAPEUTICS INC | 45.08 | 758.752M | ||
| WEED | CANOPY GROWTH CORP | N/A | 733.967M | ||
| DHT-U | DRI HEALTHCARE TRUST | 3.71 | 643.734M | ||
| CPH | CIPHER PHARMACEUTICALS INC | 18.56 | 486.64M | ||
| TSND | TERRASCEND CORP | N/A | 360.859M | ||
| HITI | HIGH TIDE INC | 15.84 | 295.344M | ||
| ACB | AURORA CANNABIS INC | 63.12 | 289.221M | ||
| OGI | ORGANIGRAM GLOBAL INC | 30.95 | 287.677M | ||
| CRDL | CARDIOL THERAPEUTICS INC-A | N/A | 218.049M |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About HVT.CA
Company Profile
Harvest One Cannabis, Inc. is a cannabis company, which develops and provides lifestyle and wellness products to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm owns and operates two subsidiaries: Dream Water TM Global and LivRelief TM. The firm operates through two segments: consumer (Dream Water and Delivra) and corporate. The consumer segment includes the marketing, distribution, and product development of liquid sleep shots and sleep powder packets as well as pain relief creams throughout Canada and the United States. The firm provides cannabis infused and non-infused consumer packaged goods (CPG) that develops and distributes health, wellness and selfcare products with a market focus on solutions for sleeplessness and pain, resulting in the reduction of fatigue and anxiety. Its subsidiaries include United Greeneries Holdings Ltd., United Greeneries Operations Ltd., United Greeneries Saskatchewan Ltd., LivVet Inc., Delivra Pharmaceuticals Inc., Delivra Corp. and LivCorp Inc.
Company Info
IPO: 2010-02-02
HARVEST ONE CANNABIS INC
Suite 404, 999 Canada Place
Vancouver BRITISH COLUMBIA V6C 3E1 CA
CEO: Gord Davey
Employees: 0
Phone: 16044499280.0
HARVEST ONE CANNABIS INC / HVT.CA FAQ
What does HARVEST ONE CANNABIS INC do?
Harvest One Cannabis, Inc. is a cannabis company, which develops and provides lifestyle and wellness products to consumers and patients in regulated markets. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2010-02-02. The firm owns and operates two subsidiaries: Dream Water TM Global and LivRelief TM. The firm operates through two segments: consumer (Dream Water and Delivra) and corporate. The consumer segment includes the marketing, distribution, and product development of liquid sleep shots and sleep powder packets as well as pain relief creams throughout Canada and the United States. The firm provides cannabis infused and non-infused consumer packaged goods (CPG) that develops and distributes health, wellness and selfcare products with a market focus on solutions for sleeplessness and pain, resulting in the reduction of fatigue and anxiety. Its subsidiaries include United Greeneries Holdings Ltd., United Greeneries Operations Ltd., United Greeneries Saskatchewan Ltd., LivVet Inc., Delivra Pharmaceuticals Inc., Delivra Corp. and LivCorp Inc.
Can you provide the latest stock price for HARVEST ONE CANNABIS INC?
The current stock price of HVT.CA is 0.03 CAD. The price decreased by -14.29% in the last trading session.
What is the dividend status of HARVEST ONE CANNABIS INC?
HVT.CA does not pay a dividend.
What is the ChartMill rating of HARVEST ONE CANNABIS INC stock?
HVT.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the PE ratio for HVT stock?
HARVEST ONE CANNABIS INC (HVT.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).
Is HARVEST ONE CANNABIS INC (HVT.CA) expected to grow?
The Revenue of HARVEST ONE CANNABIS INC (HVT.CA) is expected to grow by 50.65% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.